Product image of Memantine Grindeks (Memantine Hydrochloride) supplied by GNH India

Memantine Grindeks

Active Ingredient:
Memantine Hydrochloride
Origin:
EU

Memantine Grindeks (Memantine Hydrochloride)

Memantine hydrochloride, the active ingredient in Memantine Grindeks, is an NMDA receptor antagonist presented as a tablet for oral use. It is used to treat cognitive symptoms of Alzheimer’s disease in adults.

GNH India supplies Memantine Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Grindeks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Memantine is an NMDA receptor antagonist used in the management of Alzheimer’s disease.

  • Alzheimer’s disease (mild to moderate): improves cognition and daily functioning
  • Alzheimer’s disease (moderate): may slow functional decline
  • Alzheimer’s disease (behavioral symptoms): may reduce agitation and aggression

How It Works

  • Memantine hydrochloride binds to the NMDA (N‑methyl‑D‑aspartate) receptor at a site distinct from the glutamate binding site. By acting as a non‑competitive antagonist, it reduces excessive calcium influx caused by overstimulation, thereby limiting excitotoxic neuronal injury that contributes to cognitive decline in Alzheimer’s disease.

Side Effects

Adverse reactions may occur with memantine therapy.

Common Side Effects

  • Dizziness: transient light‑headedness, especially after dose initiation
  • Headache: mild to moderate intensity, often resolves with continued use
  • Constipation: reduced bowel movements, may require dietary adjustment
  • Fatigue: feeling of tiredness or reduced energy

Serious or Rare Side Effects

  • Seizures: rare but may occur, particularly in patients with a seizure history
  • Cardiac arrhythmia: irregular heart rhythm requiring medical evaluation
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis
  • Hepatic injury: elevated liver enzymes or hepatitis
  • Suicidal thoughts: emergent mood changes warrant immediate assessment

Precautions & Warnings

Memantine should be used with attention to patient‑specific factors.

  • Renal impairment: assess kidney function and consider dose adjustment
  • History of seizures: monitor closely for new seizure activity
  • Cardiovascular disease: evaluate risk of arrhythmia before initiating therapy
  • Concomitant NMDA antagonists: avoid additive neurotoxicity
  • Pregnancy and lactation: use only if potential benefit justifies potential risk to fetus or infant
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight

Avoid Interactions

Memantine may interact with several medicines; interactions are grouped by clinical relevance.

Major Interactions (Avoid)

  • Amantadine: combined CNS effects can increase dizziness and confusion
  • Other NMDA antagonists (e.g., ketamine): additive neurotoxicity risk
  • Strong CYP450 inhibitors (e.g., quinidine): may raise memantine plasma concentrations

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents: may diminish memantine’s cognitive benefits
  • Diuretics: altered renal clearance may affect drug levels
  • Alcohol: can enhance central nervous system depression and dizziness

Frequently Asked Questions

Memantine Grindeks contains memantine hydrochloride, which is prescribed to treat the cognitive symptoms of Alzheimer’s disease in adults. It is indicated for mild to moderate stages of the disease and may help improve memory, attention, and daily functional abilities.

Memantine works by binding to the NMDA receptor at a site separate from the glutamate binding site. This non‑competitive antagonism reduces excessive calcium entry into neurons, limiting excitotoxic damage that contributes to the neurodegeneration seen in Alzheimer’s disease.

The dosage of Memantine Grindeks is individualized by the prescribing clinician based on the patient’s condition, renal function, and tolerability. The prescriber determines the appropriate starting dose and any subsequent titration.

Safety data for memantine during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, whereas other approved agents such as donepezil, rivastigmine, and galantamine are cholinesterase inhibitors. Memantine is typically used in moderate disease or when cholinesterase inhibitors are insufficient, offering a different mechanism that may complement or replace other therapies.

Store the tablets at room temperature, below 25 °C, in the original packaging. Keep them away from moisture, heat, and direct sunlight to maintain product stability throughout its shelf life.

Memantine Grindeks is taken orally, usually with or without food, as directed by the prescriber. The tablets are swallowed whole with a glass of water; they should not be crushed, chewed, or split unless specifically advised.

Serious adverse events include seizures, cardiac arrhythmias, severe skin reactions such as Stevens‑Johnson syndrome, hepatic injury, and emergent suicidal thoughts or mood changes. Patients should seek immediate medical attention if any of these symptoms develop.

Memantine Grindeks is contraindicated in patients with known hypersensitivity to memantine or any tablet excipients. Caution is advised for individuals with severe renal impairment, uncontrolled epilepsy, or those taking other NMDA antagonists, as the risk of adverse effects may be higher.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Memantine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT